Chem42 : a Family of chemical Language Models for Target-aware Ligand Generation Chem42 is part of the Omics42 platform which includes also a family of genomic LMs and a family of proteins LMs named Gene42 and Prot42, respectively. Refer to Omics42 blog at huggingface.co/inceptionai for further deta
Aahan Singh, Engin Tekin †, Maryam Nadeem †, Nancy A. ElNaker, Mohammad Amaan Sayeed, Natalia Vassilieva, Boulbaba Ben Amor · 2025
Read Chem42 : a Family of chemical Language Models for Target-aware Ligand Generation Chem42 is part of the Omics42 platform which includes also a family of genomic LMs and a family of proteins LMs named Gene42 and Prot42, respectively. Refer to Omics42 blog at huggingface.co/inceptionai for further deta by Aahan Singh, Engin Tekin †, Maryam Nadeem †, Nancy A. ElNaker, Mohammad Amaan Sayeed, Natalia Vassilieva, Boulbaba Ben Amor (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2503-16563.txt.
Introduction
Aahan Singh and co-authors introduce Chem42, a 2025 family of chemical language models that design drug-like molecules for a chosen target. Most molecule generators learn chemistry alone and ignore the protein they must bind. That blind spot limits their use in real drug hunts.
Chem42 learns from atom-level contacts and from a sibling protein model, Prot42, which reads the target side. The cross view lets it sketch ligands that are valid, makeable, and aimed at the target. Tests across many proteins beat past tools on chemical validity, target fit, and predicted binding strength. The family also sets new marks on property guessing and conditional generation. The models are public, and the team sees a faster path from target to candidate drugs.
Catalog record
| CREATOR | Aahan Singh, Engin Tekin †, Maryam Nadeem †, Nancy A. ElNaker, Mohammad Amaan Sayeed, Natalia Vassilieva, Boulbaba Ben Amor |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2503-16563
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Chem42 : a Family of chemical Language Models for Target-aware Ligand Generation Chem42 is part of the Omics42 platform which includes also a family of genomic LMs and a family of proteins LMs named Gene42 and Prot42, respectively. Refer to Omics42 blog at huggingface.co/inceptionai for further details. Aahan Singh, Engin Tekin †, Maryam Nadeem †, Nancy A. ElNaker, Mohammad Amaan Sayeed, Natalia Vassilieva, Boulbaba Ben Amor Abstract Revolutionizing drug discovery demands more than just understanding molecular interactions—it requires generative models that can design novel ligands tailored to specific biological targets. While chemical Language Models (cLMs) have made strides in learning molecular properties, most fail to incorporate target-specific insights, restricting their ability to drive de-novo ligand generation. Chem42, a cutting-edge family of generative chemical Language Models, is designed to bridge this gap. By integrating atomic-level interactions with multimodal inputs from Prot42, a complementary protein Language Model [ SNT+ ] , Chem42 achieves a sophisticated cross-modal representation of molecular structures, interactions, and binding patterns. This innovative framework enables the creation of structurally valid, synthetically accessible ligands with enhanced target specificity. Evaluations across diverse protein targets confirm that Chem42 surpasses existing approaches in chemical validity, target-aware design, and predicted binding affinity. By reducing the search space of viable drug candidates, Chem42 could accelerate the drug discovery pipeline, offering a powerful generative AI tool for precision medicine. The Chem42 models, available at huggingface.co/inceptionai , set a new benchmark in molecule property prediction, conditional molecule generation, and target-aware ligand design. Figure 1 : Example of a Chem42-generated ligand designed to bind the Y220C mutant p53 protein (PDB ID: 8a32), shown on the right (panel (c)). For comparison, panel (a) presents the binding pose of the recently proposed small-molecule stabilizer JC769 as estimated using DiffDock-L [ CDF+24 ] , while panel (b) displays the stabilizer JC769 as originally reported in the literature [ SCDD+22 ] . The protein target context is captured using our protein Language Model (Prot42 [ SNT+ ] ) and integrated into the chemical Language Model (Chem42) to guide ligand generation. Calculated metrics—including Drug-likeness, Synthetic Accessibility, and Binding Affinity—demonstrate the effectiveness of Chem42 in achieving state-of-the-art molecular design results. 1 Introduction The discovery and design of novel therapeutic molecules remains one of the most critical challenges in drug development, requiring a precise understanding of molecular interactions and target specificity. Traditional computational methods, such as molecular docking and quantitative structure-activity relationship (QSAR) models, often struggle with the vast chemical space and the dynamic nature of molecular interactions [ SK23 ] . Recent advancements in Large Language Models (LLMs) have driven the emergence of chemical Language Models (cLMs) [ CHZ+24 , BAVP22 , ASC+22 , IDHB22 ] , which learn molecular representations to generate novel structures and predict their properties. However, these models typically lack target-specific awareness, limiting their utility for rational ligand design. Drug discovery is inherently multimodal , since ligand activity is dictated not only by the structure of a molecule, but also by its complex interactions with protein targets. To address this limitation, we introduce Chem42, a generative chemical-protein modeling framework that integrates our protein Language Model (pLM), named Prot42 [ SNT+ ] , with our chemical Language Model for target-aware ligand generation. This cross-modal approach enhances molecular design by embedding the protein context into the generative process, enabling the model to generate valid, biologically relevant, and target-specific ligands. Figure 1 illustrates how Chem42 generates a ligand for the Y220C p53 mutant protein (a tumor suppressor called also ”Guardian of the Genome”), comparing its binding pose to JC769, a known stabilizer (PDB ID: 8a32) [ SCDD+22 ] . Both ligands bind to the same pocket, demonstrating the model’s capacity to design structure-guided molecules. Given a target protein such as p53, we prompt Prot42 with its sequence, embedding its molecular features into Chem42 via cross-attention, allowing for ligand generation guided by target-specific interactions. To the best of our knowledge, this is the first framework where a cLM and a pLM collaborate to explicitly account for protein context in ligand generation, marking a significant advancement in AI-driven drug design. 2 Related Works This section reviews recent advances in chemical Language Models (cLMs) for molecule generation and property prediction, emphasizing the significance of tokenization strategies in developing effective pre-trained models. In addition, we discuss how these models facilitate advancements in drug discovery, particularly through approaches that enable target-aware ligand generation. Chemical Language Models for Molecular Generation Recent advances in chemical Language Models (cLMs) have significantly impacted molecular generation, leveraging deep learning to propose novel compounds with targeted properties. ChemFM [ CHZ+24 ] , a large-scale foundation model built on the Tiny LLaMA architecture, employs self-supervised causal language modeling on a dataset of 178 million molecules, capturing complex molecular representations without task-specific architectures. With up to 3 billion parameters, ChemFM captures complex molecular representations and generalizes across multiple chemical tasks without relying on task-specific architectures. MolGPT [ BAVP22 ] adopts a GPT-inspired transformer-decoder framework utilizing masked self-attention on SMILES representations, emphasizing molecular generation tasks. Beyond ChemFM and MolGPT, various chemical LLMs have adopted different tokenization strategies and pre-training methodologies to enhance molecular design. SMILES-BERT [ WGW+19 ] and ChemBERTa [ CGR20 ] employ masked language modeling (MLM) to refine molecular property prediction, while models such as Chemformer [ IDHB22 ] integrate MLM paired with an autoregressive token generation (ATG tokenization) strategy to improve both property prediction and molecule generation. MolXPT [ LZX+23 ] expands the capabilities of chemical LLMs by incorporating textual descriptions of molecules, excelling in molecule captioning and molecular property prediction. DrugGPT [ LGS+23 ] introduces an autoregressive model based on GPT for the discovery of protein specific ligands. Chemical Language Models (cLMs) employ distinct pretraining strategies depending on their primary objective—molecular property prediction or molecule generation. The two dominant approaches are Masked Language Modeling (MLM) and Autoregressive Token Generation (ATG), each optimized for different tasks. MLM, inspired by BERT-based models, trains by masking random tokens in molecular sequences and predicting them based on surrounding context. This bidirectional training approach enhances deep molecular understanding and improves property prediction. Notable examples include SMILES-BERT [ WGW+19 ] and ChemBERTa [ CGR20 ] , both designed for molecular property prediction, while MG-BERT [ ZWY+21 ] extends this method by integrating graph adjacency knowledge to refine molecular representations. ATG, on the other hand, generates molecular sequences token-by-token, predicting each token based on its predecessors. This method is particularly effective for de novo molecular design and reaction prediction. ChemGPT [ FSA+23 ] specializes in molecular sequence completion using ATG, while MolXPT [ LZX+23 ] enhances generative tasks by combining SMILES representations with textual descriptions, excelling in molecular captioning and property prediction. Meanwhile, DrugGPT [ LGS+23 ] , built on GPT-2, focuses on controlled generation of novel drug-like molecules. Overall, MLM-based models excel in molecular property prediction, while ATG-based models are more effective for generative tasks [ LYMW24 ] . Chemformer [ IDHB22 ] , leveraging a fusion of both strategies, stands out as a powerful model for both molecule generation and molecular property prediction. These models mark a paradigm shift from traditional rule-based approaches to scalable, data-driven strategies, enabling more efficient molecular generation, optimization, and property prediction. By integrating diverse tokenization techniques, pretraining objectives, and model architectures, AI-driven chemical